Feb 03, 2017 13:01 pm UTC| Business
PARIS, Feb. 03, 2017 -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that it received a positive data review from the Independent Data and...
Pernix Therapeutics Provides Update on Arbitration
Feb 03, 2017 13:01 pm UTC| Business
MORRISTOWN, N.J., Feb. 03, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today provided an update on the Company’s arbitration with...
Pernix Therapeutics Provides Update on Arbitration
Feb 03, 2017 13:01 pm UTC| Business
MORRISTOWN, N.J., Feb. 03, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today provided an update on the Company’s arbitration with...
PennTex Midstream Partners, LP Reports Fourth Quarter and Full Year 2016 Results
Feb 03, 2017 13:01 pm UTC| Business
HOUSTON, Feb. 03, 2017 -- PennTex Midstream Partners, LP (NASDAQ:PTXP) (the “Partnership”) today reported fourth quarter and full year 2016 financial and operational results. Fourth Quarter 2016 Results For the three...
Feb 03, 2017 13:00 pm UTC| Business
Hancock, MD, Feb. 03, 2017 -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the Company), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, is pleased to announce...
Feb 03, 2017 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that it has signed a $150 million royalty agreement with HealthCare Royalty Partners (HCR). Under the terms of...
Feb 03, 2017 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 03, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, announced the presentation of biomarker and top-line preliminary...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight